85
Views
5
CrossRef citations to date
0
Altmetric
Original Research

CircRNA circPTK2 Might Suppress Cancer Cell Invasion and Migration of Glioblastoma by Inhibiting miR-23a Maturation

, &
Pages 2767-2774 | Published online: 21 Aug 2021

References

  • BatashR, AsnaN, SchafferP, et al. Glioblastoma multiforme, diagnosis and treatment; recent literature review. Curr Med Chem. 2017;24(27):3002–3009. doi:10.2174/092986732466617051612320628521700
  • RajR, SeppäK, LuostarinenT, et al. Disparities in glioblastoma survival by case volume: a nationwide observational study. J Neurooncol. 2020;147(2):361–370. doi:10.1007/s11060-020-03428-532060840
  • Delgado-LópezPD, Corrales-GarcíaEM. Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol. 2016;18(11):1062–1071. doi:10.1007/s12094-016-1497-x26960561
  • LeeCY. Strategies of temozolomide in future glioblastoma treatment. Onco Targets Ther. 2017;10:265–270. doi:10.2147/OTT.S12066228123308
  • NamJY, De GrootJF. Treatment of glioblastoma. J Oncol Pract. 2017;13(10):629–638. doi:10.1200/JOP.2017.02553629020535
  • YanD, HaoC, Xiao-fengL, et al. Molecular mechanism of Notch signaling with special emphasis on microRNAs: implications for glioma. J Cell Physiol. 2019;234(1):158–170. doi:10.1002/jcp.26775
  • WangX, LiuS, ShaoZ, et al. Bioinformatic analysis of the potential molecular mechanism of PAK7 expression in glioblastoma. Mol Med Rep. 2020;22(2):1362–1372. doi:10.3892/mmr.2020.1120632626960
  • FestucciaC, BiordiAL, TomboliniV, et al. Targeted molecular therapy in glioblastoma. J Oncol. 2020;2020:5104876. doi:10.1155/2020/510487632411237
  • LiX, WuC, ChenN, et al. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget. 2016;7(22):33440–33450. doi:10.18632/oncotarget.796126967052
  • Le RhunE, PreusserM, RothP, et al. Molecular targeted therapy of glioblastoma. Cancer Treat Rev. 2019;80:101896. doi:10.1016/j.ctrv.2019.10189631541850
  • VoJN, CieslikM, ZhangY, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869–881. e13. doi:10.1016/j.cell.2018.12.02130735636
  • ZhaoZJ, ShenJ. Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol. 2017;14(5):514–521. doi:10.1080/15476286.2015.112216226649774
  • WangL, TongX, ZhouZ, et al. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Mol Cancer. 2018;17(1):140. doi:10.1186/s12943-018-0889-730261900
  • XuZQ, YangMG, LiuHJ, et al. Circular RNA hsa_circ_0003221 (circPTK2) promotes the proliferation and migration of bladder cancer cells. J Cell Biochem. 2018;119(4):3317–3325. doi:10.1002/jcb.2649229125888
  • YangH, LiX, MengQ, et al. CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer. Mol Cancer. 2020;19(1):13. doi:10.1186/s12943-020-1139-331973707
  • YachiK, TsudaM, KohsakaS, et al. miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition. Signal Transduct Target Ther. 2018;3:33. doi:10.1038/s41392-018-0033-630603114
  • HeY, MengC, ShaoZ, et al. MiR-23a functions as a tumor suppressor in osteosarcoma. Cell Physiol Biochem. 2014;34(5):1485–1496. doi:10.1159/00036635325322765
  • HanK, WangF, CaoC, et al. CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17. Mol Cancer. 2020;19(1):60. doi:10.1186/s12943-020-01184-832188489